• MDB Direct
  • Community Portal
  • Submit Your Big Idea
MDB Capital
  • Why Public Venture?
    • What is Public Venture?
    • Public Venture Advantage
    • How to Invest
    • MDB Outcomes
  • Why MDB?
    • MDB Difference
    • Investment Criteria
    • Curation Process
    • Outcomes
    • Launch Capabilities
    • MDB Capital Brokerage
    • Community
      • Membership Group
      • Member Criteria & Benefits
  • MDB Direct
    • Overview
    • MDB Direct
    • IRAs
    • Open an Account
  • Media
    • Videos
    • Press Releases
    • Articles
    • Reports
  • About
    • Overview
    • Our Platform
    • Value Creation
    • Join Us
    • Contact
    • Leadership Team
    • Submit Big Idea
  • MDBH Investors
    • Overview
    • Press Releases
    • SEC Filings
    • Stock Info
    • Governance
    • Email Alerts
    • IR Contact
    • Events
Select Page

ClearSign Technologies Announces Order for Multi Heater Project for Texas Petrochemical Facility

by Staff | Jul 17, 2024 | Press Releases

Project Comprised of 26 ClearSign Core™ Process Burners in Four Heaters Order Received from Birwelco USA Inc. for Fortune 500 Global Chemical Company TULSA, Okla., July 17, 2024 /PRNewswire/ — ClearSign Technologies Corporation (Nasdaq: CLIR)...

MDB Capital Announces Record Date and Expected Timing for Initial Public Offering for Invizyne Technologies

by Staff | Jul 11, 2024 | Press Releases

Addison, Texas, July 11, 2024 (GLOBE NEWSWIRE) — MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading deep technology companies, today announces the record date, allocation preference, and...

Recently Published Whitepaper from PatentVest Delves into Transformative Innovations in MASH Diagnostics

by Staff | Jul 9, 2024 | Uncategorized

Dallas, Texas, July 09, 2024 (GLOBE NEWSWIRE) — PatentVest, the first integrated IP intelligence strategy and law firm, recently published a whitepaper that presents strategic insights in the fields of Metabolic-Associated Steatohepatitis (MASH) biomarkers and...

MDB Capital Collaborates with Mayo Clinic to Advance Anti-Senescence Platform

by Staff | Jul 8, 2024 | Press Releases

ADDISON, Texas, July 08, 2024 (GLOBE NEWSWIRE) — MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading deep technology companies, today announced a collaboration through a patent and...

New PatentVest Pulse Report Delves into Transformative Innovations in MASH Diagnostics

by Staff | Jul 8, 2024 | Press Releases

Dallas, Texas, July 8, 2024 – PatentVest, the first integrated IP intelligence strategy and law firm, recently published a whitepaper that presents strategic insights in the fields of Metabolic-Associated Steatohepatitis (MASH) biomarkers and Point of Care (PoC)...

Recent Posts

  • Invizyne Technologies Announces Name Change to eXoZymes, Inc. and New Ticker Symbol
  • HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software
  • HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology
  • HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference
  • MDB Capital Holdings to Host Third Quarter 2024 Results Conference Call on Thursday November 21, 2024, at 4:30 p.m. Eastern Time

Recent Comments

    Archives

    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • July 2024
    • May 2024
    • April 2024
    • February 2024
    • January 2024
    • November 2023
    • October 2023
    • June 2023
    • May 2023
    • November 2022
    • October 2022
    • August 2022
    • July 2022
    • June 2022

    Categories

    • Press Releases
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Join Mailing List

    Terms of Use  |  Governance  |  Business Continuity  |  Member FINRA/SIPC  |  FINRA’s BrokerCheck  |  Disclosures
    © 2025 MDB Capital